In summary, AKT related parthanatos is p53 dependent and if in absence of p53 normal function parthanatos was failed to be triggered by AKT inhibition, which may partly explained why it is harder to repress CRC in the patients with p53 mutation. Here, TP53 is linked to colorectal carcinoma.